The SeqOne Genomic Analysis Platform

SeqOne is an in vitro diagnostic platform for genetic analysis, designed to help healthcare professionals interpret next-generation sequencing (NGS) and array CGH data. The platform provides qualitative and actionable results, functioning as a clinical decision support system.

Key features

It is an in vitro diagnostic medical device, Class C with CE-IVD marking and certified according to the IVDR Regulation, which ensures compliance with the highest quality and safety standards.

Its universal compatibility allows it to integrate seamlessly with any sequencer and laboratory process, advancedly optimizing the genomic workflow and improving efficiency at every stage of the analysis. With clinical validation and integration with recognized databases, SeqOne guarantees accurate and reliable diagnoses.

Furthermore, its powerful Artificial Intelligence (DiagAI) prioritizes genetic variants, facilitating the analysis and diagnosis of multiple genetic-based pathologies. Security is a priority, which is why it features a patented double encryption system and servers certified with ISO 27001 and HDS, ensuring maximum protection of patient data.

SeqOne Coverage

Clinical applications

The SeqOne genomic data tool allows healthcare professionals to have a solution that optimizes workflows and transforms complex data into clear, actionable results, with the security and confidence of having the highest standards of quality and data protection.

It facilitates informed clinical decision-making, improving efficiency in laboratories and optimizing patient care in medical areas as diverse as rare diseases, cardiology, neurology, psychiatry, carrier screening, and hereditary cancer, among many others.

SeqOne Gene Analysis

Benefits

The platform stands out for its workflow automation: it offers the possibility to automate processes, enabling fast transfers, effortless exports, and unlimited computational power.

The true optimization of the analysis lies in its AI-driven tools, which drastically accelerate variant interpretation:

DiagAI: Automatically identifies 96% of diagnostic variants. SmartPick: Instantly highlights the most likely variant, with a specificity of 92%.
SeqOne Workflow

Intended audience/user

Software solution designed for healthcare professionals and diagnostic laboratories looking to optimize the interpretation of genetic data, especially in the areas of rare diseases, hereditary disorders, carrier screening, and hereditary cancer.

SeqOne Interface

Key Features

Full integration with NGS and array-CGH data, as well as universal compatibility with any sequencer and laboratory process.
AI optimization, accelerating analysis to obtain accurate results quickly and explained for informed decision-making.
Advanced modules that allow secondary analysis from FASTQ, as well as tertiary analysis from VCF and aCGH.
Ability to perform family analyses, which are essential for a better diagnosis of hereditary diseases.
Strict regulatory compliance, including CE-IVD marking and ISO 13485 certification ensuring quality and safety in the clinical environment.
Cloud computing power that allows the processing of large volumes of data without collapsing the hospital’s infrastructure.

Area:

Molecular Genetics, Software, Software solutions for germline analysis

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)